OCULAR THERAPEUTIX, INC Basic Shares Outstanding (Weighted Average)
OCULAR THERAPEUTIX, INC (OCUL) reported Basic Shares Outstanding (Weighted Average) of 224.95 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-03
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 224.95M shares, a 30.34% increase year-over-year.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 224.10M shares, a 32.29% increase year-over-year.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 222.90M shares, a 32.60% increase year-over-year.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 183.92M shares, a 10.14% increase year-over-year.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for fiscal 2025 was 187.24M shares, a 18.31% increase from fiscal 2024.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for fiscal 2024 was 158.27M shares, a 98.26% increase from fiscal 2023.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for fiscal 2023 was 79.83M shares, a 3.84% increase from fiscal 2022.
- OCULAR THERAPEUTIX, INC weighted average number of shares outstanding, basic for fiscal 2022 was 76.88M shares, a 0.63% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 224.95M shares 10-Q · filed 2026-08-03 | 224.53M shares 10-Q · filed 2026-08-03 | 223.98M shares derived: average of 3 quarters · filed 2026-08-03 | 213.97M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 224.10M shares 10-Q · filed 2026-05-05 | 223.50M shares derived: average of 2 quarters · filed 2026-05-05 | 210.30M shares derived: average of 3 quarters · filed 2026-05-05 | 200.88M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 222.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | 203.41M shares derived: average of 2 quarters · filed 2026-02-05 | 193.14M shares derived: average of 3 quarters · filed 2026-08-03 | 187.24M shares 10-K · filed 2026-02-05 |
| 2025-09-30 | 183.92M shares 10-Q · filed 2025-11-04 | 178.26M shares derived: average of 2 quarters · filed 2026-08-03 | 175.36M shares 10-Q · filed 2025-11-04 | 173.50M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 172.59M shares 10-Q · filed 2026-08-03 | 171.00M shares 10-Q · filed 2026-08-03 | 170.03M shares derived: average of 3 quarters · filed 2026-08-03 | 169.27M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 169.40M shares 10-Q · filed 2026-05-05 | 168.74M shares derived: average of 2 quarters · filed 2026-05-05 | 168.16M shares derived: average of 3 quarters · filed 2026-05-05 | 167.58M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 168.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | 167.54M shares derived: average of 2 quarters · filed 2026-02-05 | 166.97M shares derived: average of 3 quarters · filed 2026-02-05 | 158.27M shares 10-K · filed 2026-02-05 |
| 2024-09-30 | 166.99M shares 10-Q · filed 2025-11-04 | 166.41M shares derived: average of 2 quarters · filed 2025-11-04 | 154.99M shares 10-Q · filed 2025-11-04 | 137.33M shares derived: average of 4 quarters · filed 2026-02-05 |
| 2024-06-30 | 165.82M shares 10-Q · filed 2025-08-05 | 148.92M shares 10-Q · filed 2025-08-05 | 127.44M shares derived: average of 3 quarters · filed 2026-02-05 | 115.43M shares derived: average of 4 quarters · filed 2026-02-05 |
| 2024-03-31 | 132.02M shares 10-Q · filed 2025-05-05 | 108.25M shares derived: average of 2 quarters · filed 2026-02-05 | 98.63M shares derived: average of 3 quarters · filed 2026-02-05 | 93.48M shares derived: average of 4 quarters · filed 2026-02-05 |
| 2023-12-31 | 84.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | 81.93M shares derived: average of 2 quarters · filed 2026-02-05 | 80.63M shares derived: average of 3 quarters · filed 2026-02-05 | 79.83M shares 10-K · filed 2026-02-05 |
| 2023-09-30 | 79.37M shares 10-Q · filed 2024-11-14 | 78.71M shares derived: average of 2 quarters · filed 2024-11-14 | 78.28M shares 10-Q · filed 2024-11-14 | 77.95M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 78.05M shares 10-Q · filed 2024-08-07 | 77.72M shares 10-Q · filed 2024-08-07 | 77.48M shares derived: average of 3 quarters · filed 2025-03-03 | 77.36M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 77.39M shares 10-Q · filed 2024-05-07 | 77.20M shares derived: average of 2 quarters · filed 2025-03-03 | 77.12M shares derived: average of 3 quarters · filed 2025-03-03 | 77.03M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | 77.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 76.99M shares derived: average of 2 quarters · filed 2025-03-03 | 76.92M shares derived: average of 3 quarters · filed 2025-03-03 | 76.88M shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 76.98M shares 10-Q · filed 2023-11-07 | 76.87M shares derived: average of 2 quarters · filed 2023-11-07 | 76.83M shares 10-Q · filed 2023-11-07 | 76.78M shares derived: average of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | 76.76M shares 10-Q · filed 2023-08-07 | 76.76M shares 10-Q · filed 2023-08-07 | 76.71M shares derived: average of 3 quarters · filed 2024-03-11 | 76.67M shares derived: average of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | 76.75M shares 10-Q · filed 2023-05-08 | 76.68M shares derived: average of 2 quarters · filed 2024-03-11 | 76.64M shares derived: average of 3 quarters · filed 2024-03-11 | 76.56M shares derived: average of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | 76.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 76.59M shares derived: average of 2 quarters · filed 2024-03-11 | 76.50M shares derived: average of 3 quarters · filed 2024-03-11 | 76.39M shares 10-K · filed 2024-03-11 |
| 2021-09-30 | 76.55M shares 10-Q · filed 2022-11-07 | 76.44M shares derived: average of 2 quarters · filed 2022-11-07 | 76.32M shares 10-Q · filed 2022-11-07 | 74.91M shares derived: average of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | 76.32M shares 10-Q · filed 2022-08-08 | 76.20M shares 10-Q · filed 2022-08-08 | 74.36M shares derived: average of 3 quarters · filed 2023-03-06 | 71.52M shares derived: average of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | 76.07M shares 10-Q · filed 2022-05-09 | 73.38M shares derived: average of 2 quarters · filed 2023-03-06 | 69.92M shares derived: average of 3 quarters · filed 2023-03-06 | 66.78M shares derived: average of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | 70.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 66.84M shares derived: average of 2 quarters · filed 2023-03-06 | 63.68M shares derived: average of 3 quarters · filed 2023-03-06 | 60.75M shares 10-K · filed 2023-03-06 |
| 2020-09-30 | 62.99M shares 10-Q · filed 2021-11-08 | 60.18M shares derived: average of 2 quarters · filed 2021-11-08 | 57.44M shares 10-Q · filed 2021-11-08 | 55.30M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | 57.37M shares 10-Q · filed 2021-08-09 | 54.63M shares 10-Q · filed 2021-08-09 | 52.73M shares derived: average of 3 quarters · filed 2022-02-28 | 51.29M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | 51.90M shares 10-Q · filed 2021-05-05 | 50.42M shares derived: average of 2 quarters · filed 2022-02-28 | 49.26M shares derived: average of 3 quarters · filed 2022-02-28 | |
| 2019-12-31 | 48.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 47.94M shares derived: average of 2 quarters · filed 2022-02-28 | 45.27M shares 10-K · filed 2022-02-28 | |
| 2019-09-30 | 46.94M shares 10-Q · filed 2020-11-05 | 44.05M shares 10-Q · filed 2020-11-05 | ||
| 2019-03-31 | 42.25M shares 10-Q · filed 2020-05-08 | |||
| 2018-09-30 | 39.02M shares 10-Q · filed 2019-11-12 | 37.11M shares 10-Q · filed 2019-11-12 | ||
| 2018-03-31 | 34.79M shares 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |